Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis: OARSI FDA Osteoarthritis Biomarkers Working Group

OBJECTIVE: Osteoarthritis (OA) is a chronic and slowly progressive disease for which biomarkers may be able to provide a more rapid indication of therapeutic responses to therapy than is currently available; this could accelerate and facilitate OA drug discovery and development programs. The goal of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kraus, Virginia Byers, Burnett, Bruce, Coindreau, Javier, Cottrell, Susan, Eyre, David, Gendreau, Michael, Gardiner, Jennifer, Garnero, Patrick, Hardin, John, Henrotin, Yves, Heinegård, Dick, Ko, Amy, Lohmander, Stefan, Matthews, Gloria, Menetski, Joseph, Moskowitz, Roland, Persiani, Stefano, Poole, Robin, Rousseau, Jean Charles, Todman, Martin
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568396/
https://ncbi.nlm.nih.gov/pubmed/21396468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joca.2010.08.019
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi